These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30779881)

  • 1. Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.
    Chhabra Y; Nelson CN; Plescher M; Barclay JL; Smith AG; Andrikopoulos S; Mangiafico S; Waxman DJ; Brooks AJ; Waters MJ
    FASEB J; 2019 May; 33(5):6412-6430. PubMed ID: 30779881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
    Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
    J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice.
    Liu BH; Lin YY; Wang YC; Huang CW; Chen CC; Wu SC; Mersmann HJ; Cheng WT; Ding ST
    Exp Anim; 2013; 62(4):347-60. PubMed ID: 24172199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4.
    Liu J; Nie C; Xue L; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Wang L; Li Y
    Theranostics; 2021; 11(17):8283-8300. PubMed ID: 34373742
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons.
    Cady G; Landeryou T; Garratt M; Kopchick JJ; Qi N; Garcia-Galiano D; Elias CF; Myers MG; Miller RA; Sandoval DA; Sadagurski M
    Mol Metab; 2017 May; 6(5):393-405. PubMed ID: 28462074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice.
    Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A
    Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
    Mueller KM; Kornfeld JW; Friedbichler K; Blaas L; Egger G; Esterbauer H; Hasselblatt P; Schlederer M; Haindl S; Wagner KU; Engblom D; Haemmerle G; Kratky D; Sexl V; Kenner L; Kozlov AV; Terracciano L; Zechner R; Schuetz G; Casanova E; Pospisilik JA; Heim MH; Moriggl R
    Hepatology; 2011 Oct; 54(4):1398-409. PubMed ID: 21725989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
    Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
    Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
    Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
    J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis.
    Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD
    Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease.
    Valenti L; Mendoza RM; Rametta R; Maggioni M; Kitajewski C; Shawber CJ; Pajvani UB
    Diabetes; 2013 Dec; 62(12):4052-62. PubMed ID: 23990360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis.
    DiFedele LM; He J; Bonkowski EL; Han X; Held MA; Bohan A; Menon RK; Denson LA
    Gastroenterology; 2005 May; 128(5):1278-91. PubMed ID: 15887111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.
    Sun D; Wang K; Yan Z; Zhang G; Liu S; Liu F; Hu C; Hu S
    Obes Surg; 2013 Nov; 23(11):1734-42. PubMed ID: 23700236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet.
    Baik M; Lee MS; Kang HJ; Park SJ; Piao MY; Nguyen TH; Hennighausen L
    Eur J Nutr; 2017 Mar; 56(2):569-579. PubMed ID: 26582580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of reduced growth hormone action in fatty liver disease.
    Rufinatscha K; Ress C; Folie S; Haas S; Salzmann K; Moser P; Dobner J; Weiss G; Iruzubieta P; Arias-Loste MT; Crespo J; Tilg H; Kaser S
    Hepatol Int; 2018 Sep; 12(5):474-481. PubMed ID: 30206761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
    Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
    Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.
    Gan Y; Buckels A; Liu Y; Zhang Y; Paterson AJ; Jiang J; Zinn KR; Frank SJ
    Mol Endocrinol; 2014 Nov; 28(11):1841-54. PubMed ID: 25211187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
    Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
    Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.
    Zhang L; Li X; Zhang N; Yang X; Hou T; Fu W; Yuan F; Wang L; Wen H; Tian Y; Zhang H; Lu X; Zhu WG
    Diabetes; 2020 Sep; 69(9):1887-1902. PubMed ID: 32641353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet-induced metabolic deterioration.
    Vijayakumar A; Wu Y; Sun H; Li X; Jeddy Z; Liu C; Schwartz GJ; Yakar S; LeRoith D
    Diabetes; 2012 Jan; 61(1):94-103. PubMed ID: 22187377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.